Catalent ROA 2024

Catalent ROA

-0.02

Catalent Dividend yield

Ticker

CTLT

ISIN

US1488061029

WKN

A112H2

In 2024, Catalent's return on assets (ROA) was -0.02, a -151.67% increase from the 0.05 ROA in the previous year.

Catalent Aktienanalyse

What does Catalent do?

Catalent Inc is a global leader in advanced active ingredients and medical products, as well as solutions for drug development and manufacturing. The company was founded in 1933 by the Schering brothers in the USA and has become one of the preferred partners in the pharmaceutical industry due to its innovation, flexibility, and reliability. Catalent's business model is based on providing high-quality services and products that contribute to improving human health. The company offers a wide range of solutions, from active ingredient development to drug formulation and manufacturing, clinical trials, and product packaging. Through this comprehensive offering, Catalent helps its customers accelerate their drug development and product launch. The company is divided into different business sectors with specialized solutions, including the manufacturing of biopharmaceuticals such as antibodies, cell therapies, and vaccines, as well as medical devices, active ingredient manufacturing, and pharmaceutical development and manufacturing. Catalent's services also include active ingredient development, assisting customers in all stages of drug development from identifying new active ingredients to optimizing production processes. The company specializes in formulating drugs into suitable delivery forms that ensure safe and effective use, offering a variety of oral, inhalable, and parenteral formulations. Catalent also provides clinical trials, testing the efficacy and safety of drugs in clinical trials. The company has state-of-the-art facilities and expertise to professionally and successfully support its customers in conducting clinical studies. Additionally, Catalent offers a wide range of packaging solutions, including glass bottles, plastic containers, aluminum tubes, and the finishing and packaging of finished drugs. The company has advanced production systems that enable quick and flexible packaging production in any desired size and shape. Overall, Catalent provides its customers with a comprehensive range of services and products that enable fast and effective drug development and market launch. The company's strong innovation and diverse range of expertise make it a preferred partner in the pharmaceutical industry. Catalent ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Catalent's Return on Assets (ROA)

Catalent's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Catalent's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Catalent's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Catalent’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Catalent Stock

What is the Return on Assets (ROA) of Catalent this year?

The Return on Assets (ROA) of Catalent is -0.02 undefined this year.

What was the ROA of Catalent compared to the previous year?

The ROA of Catalent has increased by -151.67% compared to the previous year.

What consequences do high ROA have for investors of Catalent?

A high ROA is advantageous for investors of Catalent, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Catalent?

A low ROA can be unfavorable for investors of Catalent as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Catalent affect the company?

An increase in ROA of Catalent can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Catalent impact the company?

A reduction in the ROA of Catalent can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Catalent?

Some factors that can influence the ROA of Catalent include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Catalent important for investors?

The ROA of Catalent is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Catalent take to improve ROA?

To improve ROA, Catalent can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Catalent pay?

Over the past 12 months, Catalent paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Catalent is expected to pay a dividend of 0 USD.

What is the dividend yield of Catalent?

The current dividend yield of Catalent is .

When does Catalent pay dividends?

Catalent pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Catalent?

Catalent paid dividends every year for the past 0 years.

What is the dividend of Catalent?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Catalent located?

Catalent is assigned to the 'Health' sector.

Wann musste ich die Aktien von Catalent kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Catalent from 4/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

When did Catalent pay the last dividend?

The last dividend was paid out on 4/29/2024.

What was the dividend of Catalent in the year 2023?

In the year 2023, Catalent distributed 0 USD as dividends.

In which currency does Catalent pay out the dividend?

The dividends of Catalent are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Catalent stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Catalent

Our stock analysis for Catalent Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Catalent Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.